Domainex: Eddy Littler, chairman
Medicines research firm Domainex has appointed Eddy Littler non-executive chairman. Littler had served as CEO of the firm previously, from May 2008 to 2016.
Littler’s other previous positions including tenures as Wellcome, GSK and Medivir. He also serves as chairman of Oxford, UK-based Neuro-Bio, which researches treatments for Alzheimer’s disease.
Retiring chair Tony Brampton said of his replacement, “His deep understanding of Domainex’s business and extensive drug discovery expertise will be invaluable to the management team led by our CEO, Tom Mander, as we pursue an accelerated growth strategy and maintain our position at the forefront of drug discovery technology providers.”